Here's Why RGAIA Considers Maravai LifeSciences Holdings' (MRVI) Margin Structure as the Best [Yahoo! Finance]
Maravai LifeSciences Holdings, Inc. - Class A common stock (MRVI)
Company Research
Source: Yahoo! Finance
A copy of the letter can be downloaded here . Strong economic growth combined with frustratingly resilient inflation defined the macroeconomic environment in the first quarter. The large caps outperformed their smaller counterparts in Q1. It may be the result of continued momentum in the market. Kindly check the top 5 stocks of the strategy to know its best picks in 2024. RGA Investment Advisors highlighted stocks like Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI ), in the first quarter 2024 investor letter. Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) is a life sciences company. The one-month return of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) was -33.69%, and its shares lost 45.43% of their value over the last 52 weeks. On June 14, 2024, Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) stock closed at $7.52 per share with a market capitalization of $1.894 billion. RGA Investment Advisors stated the following regarding Maravai LifeSciences Holdings, Inc. (NASDA
Show less
Read more
Impact Snapshot
Event Time:
MRVI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRVI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRVI alerts
High impacting Maravai LifeSciences Holdings, Inc. - Class A common stock news events
Weekly update
A roundup of the hottest topics
MRVI
News
- TriLink BioTechnologies® & Alphazyme Collaborate to Launch New CleanScribe™ RNA Polymerase [Yahoo! Finance]Yahoo! Finance
- TriLink BioTechnologies® & Alphazyme Collaborate to Launch New CleanScribe™ RNA PolymeraseBusiness Wire
- Cygnus Technologies and TriLink BioTechnologies® Collaborate to Launch AccuRes™ Host Cell DNA Quantification Kits [Yahoo! Finance]Yahoo! Finance
- Cygnus Technologies and TriLink BioTechnologies® Collaborate to Launch AccuRes™ Host Cell DNA Quantification KitsBusiness Wire
- Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $10.00 price target on the stock.MarketBeat
MRVI
Earnings
- 8/7/24 - Beat
MRVI
Sec Filings
- 9/12/24 - Form 8-K
- 8/8/24 - Form 10-Q
- 8/7/24 - Form 8-K
- MRVI's page on the SEC website